6533b860fe1ef96bd12c3236
RESEARCH PRODUCT
A proposed new model for prognostic stratification of poor-risk patients with metastatic renal cell carcinoma (mRCC) in the era of targeted therapy.
Vincenzo AdamoFrancesco MassariGiuseppe BadalamentiLuca GalliGiuseppe ProcopioJoan CarlesUmberto BassoMatteo SantoniMichele MilellaFlavia LongoDaniele SantiniAlessandra FeliciUgo De GiorgiPaolo MarchettiStefano IacobelliGaetano FacchiniGiuseppe ToniniGiuseppe Di LorenzoRoberto IacovelliFrancesco Maria Guidasubject
Cancer Researchmedicine.medical_specialtyPrognostic factorPoor riskbusiness.industrymedicine.medical_treatmenturologic and male genital diseasesmedicine.diseasePrognostic stratificationStratification (mathematics)Targeted therapyOncologyRenal cell carcinomaMedicinebusinessIntensive care medicinedescription
e15588 Background: The stratification of poor risk mRCC patients in the era of targeted therapy represents an unmet medical need. We analyzed, individually, each prognostic factor included in modif...
year | journal | country | edition | language |
---|---|---|---|---|
2014-05-20 |